Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Join this 56-minute virtual forum presentation where two Dana-Farber Cancer Institute oncologists discuss the latest advances in research and treatment approaches for patients with HER2-positive metastatic breast cancer. Learn about cutting-edge developments in targeted therapies, emerging treatment protocols, and current research findings that are shaping the management of HER2-positive metastatic breast cancer. Gain insights into how these advances are improving patient outcomes and what new therapeutic options may be available for those living with this specific subtype of metastatic breast cancer.
